We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and to... Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada, Israel, and Other Countries. Show more
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today announced that it has called an extraordinary general meeting of its shareholders (the “Extraordinary General...
Kuehn Law Encourages PGTI, TAST, TARO, and ANSS Investors to Contact Law Firm PR Newswire NEW YORK, Jan. 30, 2024 NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation...
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro PR Newswire NEW YORK, Jan. 30, 2024 NEW YORK, Jan. 30, 2024 /PRNewswire/ -- Krensavage Asset Management today sent the...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and nine months ended December 31, 2023. Quarter ended...
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for the third quarter ended December 31, 2023, after the close of market on...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 0.14228124259 | 42.17 | 42.48 | 42.05 | 20480 | 42.22730913 | CS |
4 | -0.01 | -0.0236742424243 | 42.24 | 42.49 | 41.85 | 26835 | 42.17805472 | CS |
12 | -0.8 | -1.85916802231 | 43.03 | 43.3 | 40.45 | 44918 | 42.12373683 | CS |
26 | 8.25 | 24.2789876398 | 33.98 | 45.76 | 32.67 | 42445 | 41.04320729 | CS |
52 | 17.43 | 70.2822580645 | 24.8 | 45.76 | 24.39 | 45094 | 38.93304843 | CS |
156 | -33.35 | -44.1254300079 | 75.58 | 76.4649 | 22.89 | 28153 | 42.00865807 | CS |
260 | -63.915 | -60.2148005087 | 106.145 | 109.42 | 22.89 | 35216 | 61.24869662 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions